Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.05M P/E - EPS this Y 80.80% Ern Qtrly Grth -
Income -45.65M Forward P/E -0.47 EPS next Y 62.10% 50D Avg Chg 133.00%
Sales 7.18M PEG - EPS past 5Y - 200D Avg Chg -72.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -98.00%
Recommedations 3.00 Quick Ratio 0.14 Shares Outstanding 17.07M 52W Low Chg 350.00%
Insider Own 2.42% ROA -100.17% Shares Float 3.38M Beta 0.14
Inst Own 70.75% ROE - Shares Shorted/Prior 417.09K/290.76K Price 0.24
Gross Margin - Profit Margin - Avg. Volume 63,756,935 Target Price 3.00
Oper. Margin -611.35% Earnings Date Jul 29 Volume 286,459,715 Change 54.29%
About T2 Biosystems, Inc.

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

T2 Biosystems, Inc. News
07/22/24 T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
08:00 AM T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
05/22/24 T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
05/17/24 T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
05/15/24 Sector Update: Health Care Stocks Advance Late Wednesday Afternoon
05/15/24 T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
05/14/24 T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
05/07/24 T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
05/07/24 T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
05/07/24 Q1 2024 T2 Biosystems Inc Earnings Call
05/07/24 T2 Biosystems Inc (TTOO) Q1 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst ...
05/06/24 T2 Biosystems Announces First Quarter 2024 Financial Results
05/06/24 T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
05/06/24 T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
04/24/24 T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
04/11/24 T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
03/28/24 T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
03/20/24 T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
03/19/24 T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
03/18/24 T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
TTOO Chatroom

User Image SippinOnDewkoda Posted - 6 hours ago

$TTOO

User Image WeRise1 Posted - 9 hours ago

$TTOO

User Image WeRise1 Posted - 9 hours ago

$TTOO

User Image WeRise1 Posted - 9 hours ago

$TTOO

User Image liability1 Posted - 9 hours ago

$TTOO Give me $ 4.00 by Friday !!!!

User Image liability1 Posted - 9 hours ago

$TTOO This will dump before and after earnings call !

User Image WeRise1 Posted - 9 hours ago

$TTOO Zeffy Liability 🤣🖕🤡🖕🤣

User Image Zefram Posted - 10 hours ago

$TTOO also... the guy is talking about you mostly... the captain of gif spam and useless posts. you fill up 80% of this board with your dumb yapping prattle.

User Image WeRise1 Posted - 10 hours ago

$TTOO

User Image WeRise1 Posted - 10 hours ago

$TTOO

User Image Zefram Posted - 10 hours ago

$TTOO as expected.. it's definitely someone who uses twitter for stock tips.. LOL

User Image WeRise1 Posted - 10 hours ago

$TTOO

User Image WeRise1 Posted - 10 hours ago

$TTOO Try twitter or just use mute block See I show you

User Image Zefram Posted - 10 hours ago

$TTOO i've been here for over 2 years... when did it ever have good DD? only ever had bagholders pumping a crap stock.. lol, imagine coming to stocktwits for DD. that isn't a thing...

User Image Donald_Truck Posted - 10 hours ago

$TTOO RS soon

User Image Fair_Trader42 Posted - 10 hours ago

$TTOO What a shame this board has deteriorated into. Previously, it was well populated with valued DD reviews. Now it's a bitch fest, and GIF graveyard Is anyone here still discussing Current DD ?

User Image WeRise1 Posted - 10 hours ago

$TTOO

User Image WeRise1 Posted - 10 hours ago

$TTOO No volume Short Attacks So W E AK ❤️🤣🤙

User Image Zefram Posted - 10 hours ago

$TTOO it's funny when they self own themselves... lol.

User Image WeRise1 Posted - 10 hours ago

$TTOO Down side ALL Shorts !!! Only 🤣🤣🤣Trying so hard with their little money Check the volume 🤣🤣☠️

User Image Joe32141 Posted - 10 hours ago

$TTOO

User Image WeRise1 Posted - 11 hours ago

$TTOO Hey Shorts 🤣🤣🤣 That volume means you are getting trapped 🤙

User Image WeRise1 Posted - 11 hours ago

$TTOO 🤣☠️ s h o r t s ☠️🤣

User Image liability1 Posted - 11 hours ago

$TTOO Where is Ronald McDonald or better Cheeseburgermoney LOL We got almost a week left and what did I say you will make money shorting this by the end of this month !!!

User Image WeRise1 Posted - 11 hours ago

$TTOO 🤣 V o l u m e 🤣

User Image WeRise1 Posted - 11 hours ago

$TTOO

User Image WeRise1 Posted - 11 hours ago

$TTOO Weekly chart 😏

User Image WeRise1 Posted - 11 hours ago

$TTOO

User Image Zefram Posted - 11 hours ago

$TTOO the more analyst predictions for the next earnings report come out... the lower the price drops. guess what we'll hear? LOL another quarter where they continued to not make a profit or increase sales. baggies don't even know where to find the analyst predictions. guarantee it.

User Image WeRise1 Posted - 11 hours ago

$TTOO Lower Please 😈❤️🌹

Analyst Ratings
Canaccord Genuity Hold Apr 29, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Giffin Brett A. Chief Commercial Off.. Chief Commercial Officer Feb 20 Sell 0.65 537 349 3,049 11/28/23
CR Group L.P. 10% Owner 10% Owner Sep 27 Sell 0.17 13,130,147 2,232,125 09/29/23
CR Group L.P. 10% Owner 10% Owner Sep 25 Sell 0.25 250,000 62,500 5,021,014 09/27/23
CR Group L.P. 10% Owner 10% Owner Sep 22 Sell 0.26 5,079,344 1,320,629 5,088,781 09/26/23
CR Group L.P. 10% Owner 10% Owner Sep 21 Sell 0.3 6,338,211 1,901,463 6,465,629 09/25/23
CR Group L.P. 10% Owner 10% Owner Sep 20 Sell 0.31 7,753,710 2,403,650 8,183,716 09/22/23
Gibbs Michael Terrence General Counsel General Counsel Mar 28 Sell 0.481 239 115 6,612 04/06/23
Sperzel John J III Chairman, CEO, and P.. Chairman, CEO, and President Apr 07 Buy 0.50 30,000 15,000 221,773 04/11/22
Barclay Alec Chief Operations Off.. Chief Operations Officer Apr 08 Buy 0.50 12,952 6,476 181,945 04/11/22
Gibbs Michael Terrence General Counsel General Counsel Apr 07 Buy 0.49 10,000 4,900 166,651 04/11/22
Sprague John M Chief Financial Offi.. Chief Financial Officer Apr 08 Buy 0.4767 10,000 4,767 152,350 04/11/22
Giffin Brett A. Chief Commercial Off.. Chief Commercial Officer Apr 08 Buy 0.489 10,600 5,183 10,600 04/11/22